Dual-functional inhaled Ebselen liposomes modulate the TWIST2–GPX3 redox axis to suppress fibroblast activation and attenuate pulmonary fibrosis

Idiopathic pulmonary fibrosis is a fatal interstitial lung disease characterized by persistent fibroblast activation and excessive extracellular matrix deposition. Although redox imbalance plays an important role in regulating fibroblast phenotypes, the upstream TWIST2–GPX3-associated redox mechanism and a locally deliverable strategy to suppress fibroblast activation remain incompletely defined. Dense extracellular matrix barriers and impaired local blood perfusion further limit the effective delivery of antifibrotic drugs. This study aimed to define the TWIST2–GPX3 redox axis in fibroblast activation and develop dual-functional inhaled Ebselen liposomes to attenuate fibrotic remodeling. Through multi-omics analyses, we found that GPX3 transcript expression was markedly reduced in fibrotic fibroblast populations. Mechanistically, the transcription factor TWIST2 was associated with increased GPX3 transcription and promoter histone acetylation, involving EP300-associated H3K27 acetylation. TGF-β1 stimulation reduced TWIST2 and GPX3 expression, accompanied by reactive oxygen species accumulation and increased TGF-β1/SMAD2 pathway activity, supporting a TWIST2–GPX3 redox-axis model during fibroblast activation. To modulate this fibrosis-associated redox imbalance and improve lesion-associated delivery, we engineered dual-functional inhaled Ebselen-loaded liposomes as a GPX-mimetic redox-modulating nanotherapeutic. The optimized formulation integrated L-arginine modification to support NO/MMP-associated collagen-barrier penetration and FAPI-04 conjugation to promote FAP-associated fibroblast uptake. In vitro and in vivo experiments showed that dual-functional inhaled Ebselen liposomes improved pulmonary accumulation and supported fibroblast-associated localization, suppressed fibroblast activation, and reduced fibrotic remodeling in bleomycin- and silica-induced mouse models, while exhibiting limited systemic toxicity under the tested conditions. This study identifies a TWIST2–GPX3 redox axis linked to fibroblast redox imbalance, TGF-β1/SMAD2 signaling, and fibroblast activation during pulmonary fibrosis. Dual-functional inhaled Ebselen liposomes modulated this redox imbalance by restoring GPX-like antioxidant activity and improving pulmonary/fibroblast-associated delivery. The optimized Lip@ELF formulation suppressed fibroblast activation and showed antifibrotic activity in preclinical pulmonary fibrosis models, providing a basis for further development of inhaled redox-modulating nanotherapeutic strategies.

Authors

Institutions

Publication Details

Journal
Journal of Nanobiotechnology
Published
2026-11-13
DOI
https://doi.org/10.1186/s12951-026-05204-5
Primary Topic
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Dual-functional inhaled Ebselen liposomes modulate the TWIST2–GPX3 redox axis to suppress fibroblast activation and attenuate pulmonary fibrosis

Xia Li, Yuqing Hu, Wei Wang, Yuping Xie et al.
1 links
Journal of Nanobiotechnology
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
article

Dual-functional inhaled Ebselen liposomes modulate the TWIST2–GPX3 redox axis to suppress fibroblast activation and attenuate pulmonary fibrosis

Xia Li, Yuqing Hu, Wei Wang, Yuping Xie, Meng Niu, Shibo Guan, Shaowei Ma, Jiawei Zhou
article en

Abstract

Idiopathic pulmonary fibrosis is a fatal interstitial lung disease characterized by persistent fibroblast activation and excessive extracellular matrix deposition. Although redox imbalance plays an important role in regulating fibroblast phenotypes, the upstream TWIST2–GPX3-associated redox mechanism and a locally deliverable strategy to suppress fibroblast activation remain incompletely defined. Dense extracellular matrix barriers and impaired local blood perfusion further limit the effective delivery of antifibrotic drugs. This study aimed to define the TWIST2–GPX3 redox axis in fibroblast activation and develop dual-functional inhaled Ebselen liposomes to attenuate fibrotic remodeling. Through multi-omics analyses, we found that GPX3 transcript expression was markedly reduced in fibrotic fibroblast populations. Mechanistically, the transcription factor TWIST2 was associated with increased GPX3 transcription and promoter histone acetylation, involving EP300-associated H3K27 acetylation. TGF-β1 stimulation reduced TWIST2 and GPX3 expression, accompanied by reactive oxygen species accumulation and increased TGF-β1/SMAD2 pathway activity, supporting a TWIST2–GPX3 redox-axis model during fibroblast activation. To modulate this fibrosis-associated redox imbalance and improve lesion-associated delivery, we engineered dual-functional inhaled Ebselen-loaded liposomes as a GPX-mimetic redox-modulating nanotherapeutic. The optimized formulation integrated L-arginine modification to support NO/MMP-associated collagen-barrier penetration and FAPI-04 conjugation to promote FAP-associated fibroblast uptake. In vitro and in vivo experiments showed that dual-functional inhaled Ebselen liposomes improved pulmonary accumulation and supported fibroblast-associated localization, suppressed fibroblast activation, and reduced fibrotic remodeling in bleomycin- and silica-induced mouse models, while exhibiting limited systemic toxicity under the tested conditions. This study identifies a TWIST2–GPX3 redox axis linked to fibroblast redox imbalance, TGF-β1/SMAD2 signaling, and fibroblast activation during pulmonary fibrosis. Dual-functional inhaled Ebselen liposomes modulated this redox imbalance by restoring GPX-like antioxidant activity and improving pulmonary/fibroblast-associated delivery. The optimized Lip@ELF formulation suppressed fibroblast activation and showed antifibrotic activity in preclinical pulmonary fibrosis models, providing a basis for further development of inhaled redox-modulating nanotherapeutic strategies.

Journal of Nanobiotechnology
Sheng Jing Hospital (CN), First Hospital of China Medical University (CN), China Medical University (CN)
National Key Research and Development Program of China
Good health and well-being
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon